Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon R Johnson

Showing results (71-80 of 107) with videos related to

Pageof 11
Sort By:
Contrast Media & Molecular Imaging|April 5, 2019
Accelerated <sup>19</sup>F·MRI Detection of Matrix Metalloproteinase-2/-9 through Responsive Deactivation of Paramagnetic Relaxation EnhancementHenryk M Faas, James L Krupa, Alexander J Taylor, et al.
The European Respiratory Journal|December 11, 2025
Extracellular Matrix Deposition Drives Disease Progression and Reduces Rapamycin Response in LAMDebbie Clements, Roya Babaei-Jadidi, Jan Johnson, et al.
Nature Communications|October 9, 2025
mTOR dysregulation induces IL-6 and paracrine AT2 cell senescence impeding lung repair in lymphangioleiomyomatosisRoya Babaei-Jadidi, Debbie Clements, Yixin Wu, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 13, 2015
Cardiovascular and inflammatory effects of simvastatin therapy in patients with COPD: a randomized controlled trialMichelle E John, John R Cockcroft, Tricia M McKeever, et al.
American Journal of Respiratory and Critical Care Medicine|December 15, 2016
Matrix Metalloproteinase-1 Activation Contributes to Airway Smooth Muscle Growth and Asthma SeverityShams-Un-Nisa Naveed, Debbie Clements, David J Jackson, et al.
Plos One|March 18, 2014
The role of inflammation resolution speed in airway smooth muscle mass accumulation in asthma: insight from a theoretical modelIgor L Chernyavsky, Huguette Croisier, Lloyd A C Chapman, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|December 27, 2015
The clinical profile of tuberous sclerosis complex (TSC) in the United Kingdom: A retrospective cohort study in the Clinical Practice Research Datalink (CPRD)Christopher Kingswood, Patrick Bolton, Pamela Crawford, et al.
Chest|December 23, 2021
COVID-19 in Lymphangioleiomyomatosis: An International Study of Outcomes and Impact of Mechanistic Target of Rapamycin InhibitionBruno Guedes Baldi, Elzbieta Radzikowska, Vincent Cottin, et al.
The New England Journal of Medicine|January 11, 2008
Sirolimus therapy in tuberous sclerosis or sporadic lymphangioleiomyomatosisD Mark Davies, Simon R Johnson, Anne E Tattersfield, et al.
BMJ Open Respiratory Research|January 20, 2026
Comprehensive characterisation of individuals with fibrotic interstitial lung disease: baseline insights from the INJUSTIS studyFasihul Khan, Iain Stewart, Lucy Howard, et al.
Pageof 11

Showing results (71-80 of 107) with videos related to

Sort By:
Pageof 11
Contrast Media & Molecular Imaging|April 5, 2019
Accelerated <sup>19</sup>F·MRI Detection of Matrix Metalloproteinase-2/-9 through Responsive Deactivation of Paramagnetic Relaxation EnhancementHenryk M Faas, James L Krupa, Alexander J Taylor, et al.
The European Respiratory Journal|December 11, 2025
Extracellular Matrix Deposition Drives Disease Progression and Reduces Rapamycin Response in LAMDebbie Clements, Roya Babaei-Jadidi, Jan Johnson, et al.
Nature Communications|October 9, 2025
mTOR dysregulation induces IL-6 and paracrine AT2 cell senescence impeding lung repair in lymphangioleiomyomatosisRoya Babaei-Jadidi, Debbie Clements, Yixin Wu, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 13, 2015
Cardiovascular and inflammatory effects of simvastatin therapy in patients with COPD: a randomized controlled trialMichelle E John, John R Cockcroft, Tricia M McKeever, et al.
American Journal of Respiratory and Critical Care Medicine|December 15, 2016
Matrix Metalloproteinase-1 Activation Contributes to Airway Smooth Muscle Growth and Asthma SeverityShams-Un-Nisa Naveed, Debbie Clements, David J Jackson, et al.
Plos One|March 18, 2014
The role of inflammation resolution speed in airway smooth muscle mass accumulation in asthma: insight from a theoretical modelIgor L Chernyavsky, Huguette Croisier, Lloyd A C Chapman, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|December 27, 2015
The clinical profile of tuberous sclerosis complex (TSC) in the United Kingdom: A retrospective cohort study in the Clinical Practice Research Datalink (CPRD)Christopher Kingswood, Patrick Bolton, Pamela Crawford, et al.
Chest|December 23, 2021
COVID-19 in Lymphangioleiomyomatosis: An International Study of Outcomes and Impact of Mechanistic Target of Rapamycin InhibitionBruno Guedes Baldi, Elzbieta Radzikowska, Vincent Cottin, et al.
The New England Journal of Medicine|January 11, 2008
Sirolimus therapy in tuberous sclerosis or sporadic lymphangioleiomyomatosisD Mark Davies, Simon R Johnson, Anne E Tattersfield, et al.
BMJ Open Respiratory Research|January 20, 2026
Comprehensive characterisation of individuals with fibrotic interstitial lung disease: baseline insights from the INJUSTIS studyFasihul Khan, Iain Stewart, Lucy Howard, et al.
Pageof 11